Active-ingredient Dossier
Moclobemide
Active-ingredient Dossier for Moclobemide (reversible maoi). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: AURORIX
- Brand: AMIRA
- Brand: MOCLOBEMIDE SANDOZ
- Brand: MOCLOBEMIDE-WGR
- Brand: APO-MOCLOBEMIDE
- Brand: MOCLOBEMIDE-ARX
- Therapeutic area: Psychiatry
What is
Moclobemide Moclobemide is a reversible monoamine oxidase inhibitor (MAOI).
Australian brands containing
Moclobemide — AURORIX — AMIRA — CLOBEMIX — MOCLOBEMIDE SANDOZ — MOCLOBEMIDE-WGR — APO-MOCLOBEMIDE — MOCLOBEMIDE-ARX — MOCLOBEMIDE-STR — MOCLOBERIX — MOCLOBIN
Therapeutic areas
Moclobemide is registered in neurology, with 10 brands containing the ingredient on the ARTG.
Sponsor landscape
Moclobemide is marketed by five sponsors: Arrotex Pharmaceuticals, Strides Pharma Science, Viatris, Sandoz, and GM Pharma.
PBS and regulatory activity
One brand containing moclobemide has PBS-listed items, with the latest PBS schedule date of 1 May 2026.